ARK Investment Management reported a 11.79% stake in Crispr Therapeutics CRSP · 11,313,623 sh · amendment · passive holder

Trade details

Type: 5% stake report
Report: 13G passive · amendment
Stake: 11.79%
Last report: 10.76% · filed 25/11/04
Shares held: 11,313,623 sh
Class: Common Stock
Stock: Crispr Therapeutics CRSP
Holder: ARK Investment Management
Event date: 26/03/31
Filed: 26/04/30

11.79% stake · +1.0pp from the last report

Stake: 11.79%
Last report: 10.76%
Since last report: +1.0pp

Crispr Therapeutics trades, last 26 weeks

What else happened in Crispr Therapeutics around then

Filed or reported within 30 days of the trade day · 03/01~04/30

ARK Investment Management's other 5% stake reports

ARK Investment Management
5% stakeTwist Bioscience
5% stake
Twist Bioscience
TWST
5.11% stake
3,385,850 sh
5.11% stake
Filed 09/08
ARK Investment Management
5% stake10x Genomics
5% stake
10x Genomics
TXG
8.56% stake
10,003,058 sh
8.56% stake
Filed 08/14
ARK Investment Management
5% stakeTwist Bioscience
5% stake
Twist Bioscience
TWST
7.31% stake
4,549,803 sh
7.31% stake
Filed 08/14
ARK Investment Management
5% stakeBeam Therapeutics
5% stake
Beam Therapeutics
BEAM
9.95% stake
10,234,862 sh
9.95% stake
Filed 08/14
ARK Investment Management
5% stakePacific Biosciences of California
5% stake
Pacific Biosciences of California
PACB
9.59% stake
29,781,416 sh
9.59% stake
Filed 08/14